Systemic therapy and overall survival (OS) in patients (pts) with brain metastases from HER2-positive (HER2+) metastatic breast cancer (MBC).
R. Bartsch
No relevant relationships to disclose
A. Berghoff
No relevant relationships to disclose
U. Pluschnig
No relevant relationships to disclose
Z. Bago-Horvath
No relevant relationships to disclose
P. C. Dubsky
No relevant relationships to disclose
A. Rottenfusser
No relevant relationships to disclose
C. Wenzel
No relevant relationships to disclose
M. Rudas
No relevant relationships to disclose
F. Fitzal
No relevant relationships to disclose
K. Dieckmann
No relevant relationships to disclose
M. Gnant
No relevant relationships to disclose
C. Zielinski
No relevant relationships to disclose
G. G. Steger
No relevant relationships to disclose